Terms: = Prostate cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Prognosis
1736 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
[TBL] [Abstract] [Full Text] [Related]
3. Parathyroid hormone related-protein (PTHrP) in tissues with poor prognosis in prostate cancer patients.
Zhao Y; Lu SM; Zhong B; Wang GC; Jia RP; Wang Q; Long JH
Medicine (Baltimore); 2024 Apr; 103(17):e37934. PubMed ID: 38669432
[TBL] [Abstract] [Full Text] [Related]
4. Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.
Støyten M; Knutsen T; Stikbakke E; Agledahl I; Wilsgaard T; Eggen AE; Richardsen E; Giovannucci E; Thune I; Haugnes HS
Acta Oncol; 2024 Apr; 63():154-163. PubMed ID: 38591351
[TBL] [Abstract] [Full Text] [Related]
5. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A; Osunkoya AO
Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
[TBL] [Abstract] [Full Text] [Related]
6. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
7. Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of prostate cancer.
Kalampokis N; Zabaftis C; Spinos T; Karavitakis M; Leotsakos I; Katafigiotis I; van der Poel H; Grivas N; Mitropoulos D
Curr Oncol; 2024 Feb; 31(3):1162-1169. PubMed ID: 38534919
[TBL] [Abstract] [Full Text] [Related]
8. Nadir prostate-specific antigen after salvage cryotherapy as a potential prognostic factor for oncologic outcomes.
Carbonell E; Mercader C; Sureda J; Gutiérrez A; Muñoz J; Gallardo E; Feltes N; Mases J; Valduvieco I; Vilaseca A; Franco A; Alcaraz A; Musquera M; Ribal MJ
World J Urol; 2024 Mar; 42(1):133. PubMed ID: 38478102
[TBL] [Abstract] [Full Text] [Related]
9. [Role of Bone Scan Index (BSI) in the prognosis and Treatment Efficacy in Castration-Sensitive prostate cancer Patients with Bone Metastasis].
Deguchi K; Sasaki T; Oue H; Okamoto T; Kato M; Kajiwara S; Higashi S; Masui S; Nishikawa K; Inoue T
Hinyokika Kiyo; 2024 Feb; 70(2):29-37. PubMed ID: 38447942
[TBL] [Abstract] [Full Text] [Related]
10. Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and prognosis of cancer on PET/CT.
Leung KH; Rowe SP; Sadaghiani MS; Leal JP; Mena E; Choyke PL; Du Y; Pomper MG
J Nucl Med; 2024 Apr; 65(4):643-650. PubMed ID: 38423786
[TBL] [Abstract] [Full Text] [Related]
11. Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer.
Noguchi M; Tabata M; Ito J; Kato N; Obunai K; Watanabe H; Yashima F; Watanabe Y; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Ueno H; Tada N; Yamamoto M; Hayashida K;
Open Heart; 2024 Feb; 11(1):. PubMed ID: 38417913
[TBL] [Abstract] [Full Text] [Related]
12. Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
Incesu RB; Barletta F; Tappero S; Piccinelli ML; Garcia CC; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Chun FKH; de Cobelli O; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Cancer Epidemiol; 2024 Apr; 89():102538. PubMed ID: 38377946
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of the Modeled prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant prostate cancer Treated With Taxanes in FIRSTANA.
Carrot A; Oudard S; Colomban O; Fizazi K; Maillet D; Sartor O; Freyer G; You B
JCO Clin Cancer Inform; 2024 Feb; 8():e2300208. PubMed ID: 38364191
[TBL] [Abstract] [Full Text] [Related]
14. Bone marrow metastasis in nonhematological malignancies: A study from tertiary care center.
Singh A; Rawat S; Kushwaha R; Jain M; Verma SP; Verma N; Singh US
Ann Afr Med; 2024; 23(1):91-99. PubMed ID: 38358178
[TBL] [Abstract] [Full Text] [Related]
15. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant prostate cancer.
Saylor PJ; Otani K; Balza R; Ukleja J; Pleskow H; Fisher R; Kusaka E; Otani YS; Badusi PO; Smith MR; Meneely E; Olivier K; Lowe AC; Toner M; Maheswaran S; Haber DA; Yeap BY; Lee RJ; Miyamoto DT
JCO Precis Oncol; 2024 Feb; 8():e2300230. PubMed ID: 38354328
[TBL] [Abstract] [Full Text] [Related]
16. Pan-cancer analysis reveals potential immunological and prognostic roles of METTL7A in human cancers.
Wang B; Jiang J; Luo D; Wang X
Sci Rep; 2024 Feb; 14(1):3476. PubMed ID: 38342956
[TBL] [Abstract] [Full Text] [Related]
17. Pretargeted radiotherapy and synergistic treatment of metastatic, castration-resistant prostate cancer using cross-linked, PSMA-targeted lipoic acid nanoparticles.
Dai L; Zhang X; Zhou S; Li J; Pan L; Liao C; Wang Z; Chen Y; Shen G; Li L; Tian R; Sun H; Liu Z; Zhang S; Wu H
J Mater Chem B; 2024 Feb; 12(9):2324-2333. PubMed ID: 38324337
[TBL] [Abstract] [Full Text] [Related]
18. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
De Angelis R; Demuru E; Baili P; Troussard X; Katalinic A; Chirlaque Lopez MD; Innos K; Santaquilani M; Blum M; Ventura L; Paapsi K; Galasso R; Guevara M; Randi G; Bettio M; Botta L; Guzzinati S; Dal Maso L; Rossi S;
Lancet Oncol; 2024 Mar; 25(3):293-307. PubMed ID: 38307102
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.
Inoue F; Sone K; Kumegawa K; Hachijo R; Suzuki E; Tanimoto S; Tsuboyama N; Kato K; Toyohara Y; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Mori M; Wada-Hiraike O; Oda K; Suzuki H; Maruyama R; Osuga Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299254
[TBL] [Abstract] [Full Text] [Related]
20. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
[Next]
